Dear Reader, I just caught two monsters... They're powerful. Misunderstood. And definitely rare. But I've spent over 20 years hunting them. I know exactly how to do it... The first was a 777% win in technology... The second – a 1,139% home run in biotech...which I showed my readers in just four months, start to finish. All told, they've seen seven triple-digit winners just since January, thanks to my monster-hunting approach. And an average gain of 202% on closed positions so far in 2020... If you're missing this... don't worry. You've basically missed the first inning or two of the game. Things are about to get WAY bigger and better – and I want YOU to be "in" for it... You can't miss this ONE opportunity. I'm nearly certain it's going to be the first 20-bagger stock in Stansberry Research history. One tiny company has created a drug that will fulfill a fantasy that nearly 70% of adults in the United States share. And this same drug has the power to solve a global crisis. I'm likely one of the only analysts in the world who knows about this. The company itself has deliberately kept it covered up, for strategic reasons. They literally hid the most important information in the fine print. But it's all about to become public in a big way. Which is why I'm expecting to bag another "monster" in short order. One that could easily surpass 2,000% in the coming months and years if things go how I expect. I've been authorized to put the details online for a few days, right here. Please, get them while you can. Regards, Dave Lashmet
Senior Analyst, Stansberry Research | 